HLS Therapeutics Inc. (HLTRF)
USD 2.96
(-10.03%)
USD 2.96
(-10.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.69 Million | 16.94 Million | 16.42 Million | 9.34 Million | 26.4 Million | 32.74 Million |
| Net Income | -28.03 Million | -23.59 Million | -13.11 Million | -15.33 Million | -19.55 Million | -24.8 Million |
| Depreciation & Amortization | 32.52 Million | 34.4 Million | 30.26 Million | 33.18 Million | 32.51 Million | 32.39 Million |
| Deferred income taxes | -708.76 Thousand | 138 Thousand | 1.13 Million | -2.48 Million | -2.24 Million | -5.44 Million |
| Stock-based compensation | -538 Thousand | 2.92 Million | 2.35 Million | 2.53 Million | 3.76 Million | 1.06 Million |
| Change in working capital | 5.12 Million | 1.54 Million | -3.02 Million | -7.66 Million | 1.54 Million | 6.45 Million |
| Other non-cash items | 6.32 Million | 1.53 Million | -1.18 Million | -894 Thousand | 10.38 Million | 23.5 Million |
| Investing Cash Flow | -192.46 Thousand | -10.14 Million | -4.51 Million | -44.67 Million | -15.35 Million | -14.58 Million |
| Investments in PPE | -192.46 Thousand | -10.14 Million | -4.51 Million | -44.67 Million | -2.55 Million | -781 Thousand |
| Acquisitions | - | - | -3.78 Million | -12.68 Million | -13.09 Million | -13.8 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -148 Thousand | -9.6 Million | 3.78 Million | 12.68 Million | 297.58 Thousand | -14.48 Million |
| Financing Cash Flow | -14.63 Million | -6.85 Million | -11.39 Million | 9.56 Million | 23.94 Million | -42.85 Million |
| Debt repayment | -9.46 Million | -10.44 Million | -11.13 Million | -6.66 Million | -5.45 Million | -152.52 Million |
| Dividends payments | -2.44 Million | -4.76 Million | -5.07 Million | -4.99 Million | -4.43 Million | -1.04 Million |
| Common Stock Repurchased | -1.55 Million | -998 Thousand | -47 Thousand | -1.72 Million | 51 Thousand | -924 Thousand |
| Common Stock Issuance | 136.45 Thousand | 10.18 Million | 4.86 Million | 1.72 Million | 37.32 Million | 19.47 Million |
| Other Financing Activities | -1.22 Million | -639 Thousand | 4.9 Million | 20.97 Million | -3.64 Million | 92.16 Million |
| Accounts receivables | 751.53 Thousand | -71 Thousand | 1.04 Million | 1.52 Million | 6.06 Million | 7.28 Million |
| Accounts payables | 2.02 Million | 3.23 Million | -3.64 Million | -70 Thousand | -2.03 Million | -318 Thousand |
| Inventory | -673.12 Thousand | -622 Thousand | 1.76 Million | -8.07 Million | -501 Thousand | -236 Thousand |
| Other working capital | 3.02 Million | -999 Thousand | -2.18 Million | -1.03 Million | -1.97 Million | -279 Thousand |
| Cash at beginning of period | 20.71 Million | 21.17 Million | 20.61 Million | 47.07 Million | 10.93 Million | 36.21 Million |
| Cash at end of period | 21.83 Million | 20.72 Million | 21.17 Million | 20.61 Million | 47.07 Million | 10.93 Million |
| Capital Expenditure | -192.46 Thousand | -10.14 Million | -4.51 Million | -44.67 Million | -2.55 Million | -781 Thousand |
| Effect of forex changes on cash | 268 Thousand | -394 Thousand | 46 Thousand | -697 Thousand | 1.15 Million | -599 Thousand |
| Net cash flow / Change in cash | 1.12 Million | -456 Thousand | 567 Thousand | -26.46 Million | 36.14 Million | -25.28 Million |
| Free Cash Flow | 14.5 Million | 6.79 Million | 11.91 Million | -35.33 Million | 23.84 Million | 31.96 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.68 Million | -6.07 Million | -5.55 Million | -28.03 Million | -6.9 Million | -9.43 Million |
| Depreciation & Amortization | 5.85 Million | 5.89 Million | 7.24 Million | 32.52 Million | 8.2 Million | 8.36 Million |
| Deferred income taxes | 3.83 Million | -60.72 Thousand | 107.27 Thousand | -708.76 Thousand | -541 Thousand | -85 Thousand |
| Stock-based compensation | 427 Thousand | 256 Thousand | -601 Thousand | -538 Thousand | -19 Thousand | 137 Thousand |
| Change in working capital | 839.05 Thousand | 299.65 Thousand | 1.11 Million | 5.12 Million | 2.39 Million | 575 Thousand |
| Other non-cash items | 8.15 Million | 12.42 Million | 1.51 Million | 6.32 Million | 2.22 Million | 3.11 Million |
| Investing Cash Flow | 13.15 Million | -1991.07 | -14.62 Thousand | -192.46 Thousand | -40 Thousand | -135 Thousand |
| Investments in PPE | -14.60 | -1991.07 | -14.62 Thousand | -192.46 Thousand | -40 Thousand | -27 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 13.15 Million | - | - | -148 Thousand | -40 Thousand | -108 Thousand |
| Financing Cash Flow | -1.92 Million | -2.48 Million | -3.88 Million | -14.63 Million | -4.29 Million | -2.94 Million |
| Debt repayment | -1.49 Million | -2.06 Million | -3.3 Million | -9.46 Million | -2.32 Million | -1.54 Million |
| Dividends payments | - | - | -5041.59 | -2.44 Million | -1594.03 | -1.23 Million |
| Common Stock Repurchased | -316.75 Thousand | -281.73 Thousand | -580 Thousand | -1.55 Million | -603 Thousand | -185 Thousand |
| Common Stock Issuance | - | - | 281.72 | 136.45 Thousand | -89.07 | -479.90 |
| Other Financing Activities | -658 Thousand | -533 Thousand | - | -1.22 Million | -1.36 Million | - |
| Accounts receivables | 349.59 Thousand | 833.26 Thousand | 226.13 Thousand | 751.53 Thousand | 1.12 Million | -1.64 Million |
| Accounts payables | -965.73 Thousand | -516.68 Thousand | -381.98 Thousand | 2.02 Million | 1.47 Million | -521 Thousand |
| Inventory | 1.17 Million | -766.56 Thousand | -624.34 Thousand | -673.12 Thousand | 1.02 Million | 696 Thousand |
| Other working capital | 280.47 Thousand | 749.63 Thousand | 1.89 Million | 3.02 Million | -1.22 Million | 2.04 Million |
| Cash at beginning of period | 19.42 Million | 21.83 Million | 21.7 Million | 20.71 Million | 20.93 Million | 21.21 Million |
| Cash at end of period | 32.51 Million | 19.42 Million | 21.83 Million | 21.83 Million | 21.8 Million | 20.93 Million |
| Capital Expenditure | -14.60 | -1991.07 | -14.62 Thousand | -192.46 Thousand | -40 Thousand | -27 Thousand |
| Effect of forex changes on cash | -117 Thousand | -251 Thousand | 310 Thousand | 268 Thousand | -160 Thousand | 133 Thousand |
| Net cash flow / Change in cash | 13.08 Million | -2.41 Million | 136.2 Thousand | 1.12 Million | 876 Thousand | -282 Thousand |
| Free Cash Flow | 1.84 Million | 241.91 Thousand | 3.81 Million | 14.5 Million | 5.32 Million | 2.64 Million |
BDRX
CBIT
SBKFF
ZWACK
MOV
CULL